Prospective, real‐time monitoring of pegylated Escherichia coli and Erwinia asparaginase therapy in childhood acute lymphoblastic leukaemia and non‐Hodgkin lymphoma in Belgium-Reference-Cited by-同舟云学术

Prospective, real‐time monitoring of pegylated Escherichia coli and Erwinia asparaginase therapy in childhood acute lymphoblastic leukaemia and non‐Hodgkin lymphoma in Belgium

Published:2020-02-14 Issue:1 Volume:190 Page:105-114
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Mondelaers Veerle¹^ORCID,Ferster Alina²,Uyttebroeck Anne³,Brichard Bénédicte⁴,Werff ten Bosch Jutte⁵,Norga Koenraad⁶,Francotte Nadine⁷,Piette Caroline⁸,Vandemeulebroecke Katrien⁹,Verbeke Charlotte¹⁰,Schmidt Susanne¹⁰,Benoit Yves¹,Lammens Tim¹,De Moerloose Barbara¹

Affiliation:

1. Pediatric Hematology‐Oncology and Stem Cell Transplantation Ghent University Hospital and Cancer Research Institute Ghent Ghent Belgium

2. Pediatric Hematology‐Oncology Hôpital Universitaire des Enfants Reine Fabiola (HUDERF‐UKZKF) Brussels Belgium

3. Pediatric Hematology‐Oncology University Hospital Gasthuisberg Leuven Belgium

4. Pediatric Hematology‐Oncology Cliniques Universitaires Saint‐Luc (UCL) Brussels Belgium

5. Pediatric Hematology‐Oncology UZ Brussel Brussels Belgium

6. Pediatric Hematology‐Oncology University Hospital Antwerp Antwerp Belgium

7. Department of Pediatric Oncology CHC‐ Hospital of Hope Montegnée Belgium

8. Department of Pediatric Oncology CHR Citadelle Liège Belgium

9. Pediatric Hematology‐Oncology and Stem Cell Transplantation Ghent University Hospital GhentBelgium

10. Faculty of Medicine and Health Sciences Ghent University Ghent Belgium

Funder

Universitair Ziekenhuis Gent

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16495

Reference30 articles.

1. Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries

2. Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study

3. Lack of asparagine depletion in the cerebrospinal fluid after one intravenous dose of PEG-asparaginase: a window study at initial diagnosis of childhood ALL

4. Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study

5. Comparison of Hypersensitivity Reactions to PEG-Asparaginase in Children After Intravenous and Intramuscular Administration

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial;Journal of Clinical Oncology;2024-05-10

2. l-Asparaginase from Solanum lycopersicum as a Nutraceutical for Acute Lymphoblastic Leukemia;ACS Omega;2024-01-05

3. A Review of L-Asparaginase Hypersensitivity in Paediatric Acute Lymphoblastic Leukaemia Patients with Regard to the Measurement of Anti-Asparaginase Antibodies and Their Genetic Predisposition;Malaysian Journal of Medical Sciences;2023-10-30

4. Asparaginase therapy in patients with acute lymphoblastic leukemia: expert opinion on use and toxicity management;Leukemia & Lymphoma;2023-02-13

5. Asparaginase activity monitoring in pediatric acute lymphoblastic leukemia: A cross‐sectional nationwide study in Spain;Cancer Reports;2022-10-28